Daniel Siegel
VP Technology & Ip Assessment at Cbd Technologies, Ltd. Futuragene Inc
Based in Israel
7-day free trial · no credit card
Seniority
Vp
Department
Other
Location
Israel
Industry
Biotechnology
Company size
1
Contact information
Reveal Daniel's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
d•••••••@futuragene.com
Phone
5 credits+972 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Daniel Siegel
Daniel Siegel is the VP Technology and IP Assessment of FuturaGene Ltd, a world leader in agricultural biotechnology. The Company develops and commercializes plants with modified traits enhancing and protecting yields, improving processability in the forestry, biofuels, biopower and agricultural sectors. FuturaGene is a fully owned subsidiary of the Suzano Group. The Brazilian-based Suzano Group is a leader in forestry, pulp, paper and renewable fuel. Dan Siegel was formerly the VP Director IP Development & Strategy at Meytav Technological Incubator, a leading Israeli medical device and biotechnology incubator. Dan Siegel has provided expert advice on IP strategy, technology valuation and Intellectual Property Landscaping to several leading Israeli medical device companies and has been directly involved in due diligence processes leading to acquisitions. Dan Siegel serves as an advisor to several medical device companies in IP Strategy and Technology Assessment. Specialties: Technology and IP assessment, risk management, Intellectual Property strategy and Intellectual Property Landscaping
Build a list of verified contacts at Cbd Technologies, Ltd. Futuragene Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Daniel
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime